Açiq mənbələrdən foto.

Açiq mənbələrdən foto.

Baku/09.02.21/Turan: The Azerbaijani Ministry of Health approved the clinical trials in the country for the joint use of Sputnik V and AstraZeneca vaccines. These studies are expected to begin by the end of February this year.

The Gamaleya Research Center, the Russian Direct Investment Fund (RDIF), AstraZeneca and the R-Pharm group of companies signed a memorandum of cooperation in December 2020 on developing a vaccine against coronavirus.

The study aims to evaluate the immunogenicity and safety of the combined use of Sputnik V vaccine and a vaccine developed by AstraZeneca in collaboration with the University of Oxford. The research program will last 6 months in several countries. It is planned to involve 100 volunteers from each country in the study. -16D-

 

Leave a review

Social

Follow us on social networks

News Line